Effects of Selected Polysorbate and Sucrose Ester Emulsifiers on the Physicochemical Properties of Astaxanthin Nanodispersions
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Sucrose Octanoate Esters Crop 1 2 Identification of Petitioned Substance
Sucrose Octanoate Esters Crop 1 2 Identification of Petitioned Substance 3 Chemical Names: CAS Numbers: 4 sucrose octanoate esters 15 CAS NO. 42922-74-7 (monooctanoate), 58064-47-4 5 16 (dioctanoate) 6 Other Name: 7 (∀-D-glucopyranosyl-∃-D-fructofuranosyl- Other Codes: 8 octanoate), mono-, di-, and triesters of sucrose 17 OPP Chemical Code: 035300 9 octanoate 10 11 Trade Names: 12 Avachem Sucrose Octanoate Manufacturing Use 13 Product 14 Avachem Sucrose Octanoate [40%] 18 19 Characterization of Petitioned Substance 20 21 Composition of the Substance: 22 23 Sucrose octanoate esters (SOEs) belong to the organic chemical family sucrose fatty acid esters (SFAEs).1 24 SFAEs are surfactants (or surface active agents) that lower the surface tension of a liquid, allowing easier 25 spreading and evaporation. Surfactants are usually organic compounds that contain both hydrophobic 26 (fat-soluble) and hydrophilic (water-soluble) groups (Wikipedia, n. d.). SFAEs have sucrose residues as the 27 hydrophilic group and fatty acid residues as the lipophilic group. SOEs are manufactured from sucrose 28 (table sugar) and an octanoic acid ester commonly found in plants and animals. Sucrose esters, as a class of 29 related compounds, vary depending on the number and locations of esters attached to the sucrose 30 molecules. Sucrose has eight potential places where individual esters may attach (Montello Inc., n. d.). The 31 substance under review is a mixture of mono-, di-, and triesters. 32 33 Sucrose esters were first isolated when researchers investigated the insecticidal properties of the tobacco 34 leaf hairs. This insecticidal property of sucrose esters acts by dissolving the waxy protective coating 35 (cuticle) of target pests, causing them to dry out and die (U.S. -
Sucrose Esters in Gel-To-Milk Emulsion Concepts
For know-how in sucrose ester techniques Sucrose esters in gel-to-milk emulsion concepts EXPERIENCE OUR EXPERTISE! Introduction Sisterna B.V.is a young and flexible organisation that is solely active in the promotion and sales of Sisterna® sucrose esters. Furthermore Sisterna has developed countless proven and innovative applications of these natural and multifunctional emulsifiers for the cosmetic industry. Sisterna® sucrose esters are based on sucrose and vegetable fatty acids and are a unique range of high quality, non-ionic emulsifiers with an exceptional performance and mildness to skin and eyes. Besides emulsification Sisterna® sucrose esters can offer other unique benefits to personal care formulations. Sisterna has developed various interesting emulsion concepts, such as a gel-to-milk concept, the subject of this paper. Sisterna’s exclusive distributor network ensures the availability and technological knowhow of sucrose esters in personal care applications in the Western Hemisphere. 2 Summary Sisterna® sucrose esters with a high HLB are very suitable emulsifiers for the development of natural 'oil gels' that turn into milk when diluted upon use. These 'oil gels' are in fact concentrated oil-in-glycerin (O/G) emulsions that can be produced by using standard high shear homogenising equipment. Very narrow oil droplet size emulsions with average oil droplet sizes of 300 - 500 micron are obtained. By using just 2% of one single high HLB sucrose ester, preferably sucrose palmitate, it is already possible to produce a gel-to-milk concept containing 60% of oil. Such a concept is very suitable for make-up cleansing. The high oil content will allow to remove all impurities. -
Docetaxel Formulation in Polysorbate 80
American Journal of Pharmacology & Therapeutics Research Article Docetaxel Formulation in Polysorbate 80: A Complex and Sensitive System - Jean-René Authelin1*, Doris Andert2, Lucile Boilait3, Jean-Jacques Nguyen-Huu1, Yan-Yan Zhang4 and Ping Ni1 1Sanofi R&D, 94400 Vitry sur Seine, France 2Sanofi Industrial Affairs, 65926 Frankfurt am Main, Germany 3Sanofi R&D, 34000 Montpellier, France 4Sanofi R&D, 200040 Shanghai, China *Address for Correspondence: Jean-René Authelin, Sanofi R&D, 94400 Vitry sur Seine, France, E-mail: Submitted: 21 September 2020; Approved: 25 September 2020; Published: 30 September 2020 Cite this article: Authelin JR, Andert D, Boilait L, Nguyen-Huu JJ, Zhang YY, Ni P. Docetaxel Formulation in Polysorbate 80: A Complex and Sensitive System. Am J Pharmacol Ther. 2020 Sep 30;4(1): 001-006. doi: 10.37871/ajpt.id19 Copyright: © 2020 Authelin JR, et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. American Journal of Pharmacology & Therapeutics ABSTRACT Background: Innovator docetaxel (in Taxotere reference product), a poorly water-soluble agent with a narrow therapeutic index, is developed as a solution in Polysorbate 80 and ethanol. Such formulations form metastable micelles and are considered complex parenterals. Formulation process control impacts quality attributes effi cacy and safety. Characterization of micellar systems in infusion bags is required to ensure good biopharmaceutical performance and equivalence of docetaxel generic formulation. Methods: HPLC, GC, water content (Karl Fischer) and pH were used to characterize chemical properties and oxygen content in the vial headspace. -
Polysorbate 80
Pharmacopeial Forum Vol. 35(4) [July±Aug. 2009] STAGE 6 HARMONIZATION 1019 BRIEFING ASSAY • COMPOSITION OF FATTY ACIDS Diluent: 20 g/L sodium hydroxide in methanol Polysorbate 80. The European Pharmacopoeia is the coordi- Saturated sodium chloride solution: Sodium chloride and nating pharmacopeia for the international harmonization of the water (1:2). Before use, decant the solution from any undis- compendial standards for the Polysorbate 80 monograph, as solved substance and filter, if necessary. part of the process of international harmonization of Reference solution A: Prepare 0.50 g of the mixture of cali- monographs and general analytical methods of the European, brating substances with the composition described in Table 1. Japanese, and United States pharmacopeias. The following mon- Dissolve in heptane, and dilute with heptane to 50.0 mL. Reference solution B: Reference solution A in heptane (1 in ograph, which represents the ADOPTION STAGE 6 document, Stage 6 Harmonization is based on the corresponding monograph for Polysorbate 80 10) that was prepared by the European Pharmacopoeia and pub- Reference solution C: Prepare 0.50 g of a mixture of fatty lished in PF 33(5) [Sept.±Oct. 2007]. The European Pharmaco- acid methyl esters, which corresponds to the composition of poeia draft was based in part on comments from the Japanese the substance to be examined. Dissolve in heptane, and dilute Pharmacopoeia and the United States Pharmacopeia in response with heptane to 50.0 mL. [NOTEÐCommercially available mix- to the Provisional Harmonized Text Stage 5A and 5B drafts pre- tures of fatty acid methyl esters may also be used.] pared by the European Pharmacopoeia. -
Immediate Hypersensitivity Reactions Caused by Drug Excipients: a Literature Review Caballero ML, Quirce S
REVIEWS Immediate Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review Caballero ML, Quirce S Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain J Investig Allergol Clin Immunol 2020; Vol. 30(2): 86-100 doi: 10.18176/jiaci.0476 Abstract The European Medicines Agency defines excipients as the constituents of a pharmaceutical form apart from the active substance. Immediate hypersensitivity reactions (IHRs) caused by excipients contained in the formulation of medications have been described. However, there are no data on the prevalence of IHRs due to drug excipients. Clinical manifestations of allergy to excipients can range from skin disorders to life-threatening systemic reactions. The aim of this study was to review the literature on allergy to pharmaceutical excipients and to record the IHRs described with various types of medications, specifically reactions due to the excipients contained in their formulations. The cases reported were sorted alphabetically by type of medication and excipient in order to obtain a list of the excipients most frequently involved for each type of medication. Key words: Allergy. Drug immediate hypersensitivity reaction. Excipient. Pharmaceutical excipients. Resumen La Agencia Europea de Medicamentos define los excipientes como los componentes de una forma farmacéutica diferenciados del principio activo. Se han descrito reacciones de hipersensibilidad inmediata causadas por los excipientes contenidos en la formulación de medicamentos. Sin embargo, no hay datos sobre la prevalencia de dichas reacciones. Las manifestaciones clínicas de la alergia a los excipientes pueden ir desde trastornos de la piel hasta reacciones sistémicas que ponen en peligro la vida. El objetivo de este estudio fue realizar una revisión de la literatura sobre la alergia a los excipientes farmacéuticos y recopilar las reacciones inmediatas descritas con diferentes tipos de medicamento, debido solo a excipientes contenidos en sus formulaciones. -
Process for the Production of a Surfactant Containing Sucrose Esters
Patentamt JEuropaischesEuropean Patent Office © Publication number: 0 031 191 Office europeen des brevets A1 © EUROPEAN PATENT APPLICATION © Application number: 80302785.3 © Int. CI.3: C 07 H 15/06 © Date of filing: 13.08.80 © Priority: 19.12.79 GB 7943762 © Inventor: Galleymore, Harry Reginald 01.05.80 GB 8014370 69 High Street Bathford Bath BA1 7SZAvon(GB) © Date of publication of application: (72) Inventor: James, Kenneth 01.07.81 Bulletin 81/26 34, Crawford Close Earley Reading Berkshire(GB) © Designated Contracting States: AT BE CH DE FR IT LI LU NL SE ©) Inventor: Jones, Haydn Frederick 27, Malone Road Woodley © Applicant: TATE & LYLE PATENT HOLDINGS LIMITED Reading Berkshire(GB) 5th Floor, Triningham Building Front Street Hamilton 5(BM) © Inventor: Bhardwaj, Chaman Lai 31 Crescent Road Tilehurst © Applicant: TALRES DEVELOPMENT (N.A.) N.V. Reading Berkshire RG3 5AH(GB) Breedestraat 39C Curacao, Netherlands Antiiles(NL) (72) Inventor: Plant, James Stephen Deceased © Designated Contracting States: G(GB) BE © Representative: Ablewhite, Alan James et al, MARKS & CLERK 57/60 Lincoln's Inn Fields London WC2A3LS(GB) © Process for the production of a surfactant containing sucrose esters. The process for the preparation of a surfactant mixture containing sucrose mono-and di-esters, by reacting a starting mixture including solid particulate sucrose, at least one trig- lyceride of a fatty acid having at least 8 carbon atoms and a basictransesterification catalyst, atatemperature offrom 110 to 140°C at atmospheric pressure and in the absence of any solvent, is improved by using a starting mixture which:- (a) contains a di and/or mono-glyceride in an amount to provide a hydroxyl value of greater than 500 mg KOH/100g of starting mixture; (b) contains at least 10% by weight of a fatty acid soap in addition to the basic transesterification catalyst, at least 50% by weight of the soap being potassium soap, and (c) (when the soap content is less than 20% by weight) contains at least 25% by weight of sucrose. -
Nanoemulsion Including Sucrose Fatty Acid Ester Nanoemulsionen Enthaltend Saccharosefettsäureester Nanoemulsions Comprenant Des Ester D’Acide Gras De Sucrose
(19) TZZ ¥__T (11) EP 2 563 164 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A23L 29/10 (2016.01) A23L 33/10 (2016.01) 29.06.2016 Bulletin 2016/26 A23L 33/15 (2016.01) A61K 9/107 (2006.01) (21) Application number: 11713391.8 (86) International application number: PCT/US2011/000538 (22) Date of filing: 22.03.2011 (87) International publication number: WO 2011/119228 (29.09.2011 Gazette 2011/39) (54) NANOEMULSION INCLUDING SUCROSE FATTY ACID ESTER NANOEMULSIONEN ENTHALTEND SACCHAROSEFETTSÄUREESTER NANOEMULSIONS COMPRENANT DES ESTER D’ACIDE GRAS DE SUCROSE (84) Designated Contracting States: (72) Inventor: BROMLEY, Philip, J. AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Fullerton, CA 92832 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (74) Representative: Boult Wade Tennant Designated Extension States: Verulam Gardens BA ME 70 Gray’s Inn Road London WC1X 8BT (GB) (30) Priority: 23.03.2010 US 340944 P (56) References cited: (43) Date of publication of application: WO-A1-2008/039564 WO-A1-2009/029046 06.03.2013 Bulletin 2013/10 WO-A1-2010/008762 DE-A1-102008 015 366 US-A1- 2009 297 665 (73) Proprietor: VIRUN, INC. Walnut, CA 91789 (US) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations. -
Synthèse Et Évaluation Pharmacologique D'analogues Préactivés De L'ifosfamide
Synthèse et évaluation pharmacologique d’analogues préactivés de l’ifosfamide : prodrogues et nanoparticules à visée antitumorale Charles Skarbek To cite this version: Charles Skarbek. Synthèse et évaluation pharmacologique d’analogues préactivés de l’ifosfamide : prodrogues et nanoparticules à visée antitumorale. Pharmacie galénique. Université Paris Saclay (COmUE), 2017. Français. NNT : 2017SACLS247. tel-01618196 HAL Id: tel-01618196 https://tel.archives-ouvertes.fr/tel-01618196 Submitted on 17 Oct 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. 1 2 REMERCIEMENTS Je voudrais exprimer mes remerciements aux membres du jury, aux rapporteurs : les Maitres de Conférences Joseph Ciccolini et Sylvie Bégu, ainsi qu’aux examinateurs : les professeurs Elias Fattal, Thierry Martens et Nathalie Chaput ainsi que les docteurs Alain Herrera et Emilie Roger, d’avoir accepté de juger mon travail de thèse. Je souhaite remercier le Dr Lluis Mir, directeur de l’unité UMR CNRS 8203 pour m’avoir accueilli dans son laboratoire « vectorologie et thérapeutiques anticancéreuses » et de m’avoir permis de réaliser mes travaux de thèse après mon stage de Master 2, au cours desquels j’ai pu développer la formulation des dérivés préactivés de l’ifosfamide et réaliser leur évaluation pharmacologique. -
United States Patent (19) 11 Patent Number: 5,858,330 Boltri Et Al
USOO585833OA United States Patent (19) 11 Patent Number: 5,858,330 Boltri et al. (45) Date of Patent: *Jan. 12, 1999 54). PHARMACEUTICAL FORMULATIONS IN 52 U.S. Cl. ............................ 424/45; 424/450; 424/484; FORM OF THIXOTROPIC GEL 424/401; 514/772 58 Field of Search ............................. 424/45, 450, 484; 75 Inventors: Luigi Boltri, Antonietta Coppola; 514/772 Marco Gentile; Gaetano Clavenna, all of Milan, Italy 56) References Cited 73) ASSignee: Dompe' S.p.A., L'Aquila, Italy U.S. PATENT DOCUMENTS * Notice: This patent issued on a continued pros- 4,992.256 2/1991 Skaggs ...................................... 424/45 ecution application filed under 37 CFR 4,996,240 2/1991 Osipow et al.. 1.53(d), and is subject to the twenty year patent term provisions of 35 U.S.C. Primary Examiner Rebecca Cook 154(a)(2). Attorney, Agent, or Firm-Griffin, Butler, Whisenhunt & Szipl, LLP 22 Filed: Mar 18, 1996 The present invention relates to a topical formulation of 30 Foreign Application Priority Data gel-like consistency, but nebulizable by a mechanical pump, containing colloidal Silices as gelifying agent. Mar. 22, 1995 IT Italy ................................. MI95AO568 (51) Int. Cl. .................................................. A61L 9/04 9 Claims, No Drawings 5,858,330 1 2 PHARMACEUTICAL FORMULATIONS IN Surface area from 50 to 400 m/g FORM OF THXOTROPIC GEL Average diameter from 7 to 40 nm. All of these materials give Similar gelification phenomena The present invention relates to a topical formulation of but, Since gelification occurs through adsorption, the Surface gel-like consistency, but nebulizable by mechanical pump, area characteristics become paramount for the choice of the containing colloidal Silices as gelifying agent. -
United States Patent (19) 11) 4,298,730 Galleymore Et Al
United States Patent (19) 11) 4,298,730 Galleymore et al. 45 Nov. 3, 1981 54 PROCESS FOR THE PRODUCTION OF A 3,867,301 2/1975 Watanabe............................ 252/132 SURFACTANT CONTAINING SUCROSE 3,963,699 6/1976 Rizzi............. ... 534/119 ESTERS 3,996,206 12/1976 Parker. 536/119 4,032,702 6/1977 James .................................. 536/119 75 Inventors: Harry R. Galleymore, Bath; Kenneth James, Reading; Haydn F. Jones, FOREIGN PATENT DOCUMENTS Reading; Chaman L. Bhardwaj, 1399053 6/1975 United Kingdom................ 536/119 Reading, all of England; James S. Plant, deceased, late of Reading, Primary Examiner-Dennis L. Albrecht England; by Aline P. Plant, Attorney, Agent, or Firm-Ostrolenk, Faber, Gerb & administrator, Manchester, England Soffen 73) Assignee: Tahres Development (N.A.) N.V., (57) ABSTRACT Curacao, Netherlands Antilles The process for the preparation of a surfactant mixture containing sucrose mono- and di-esters, by reacting a 21) Appl. No.: 174,277 starting mixture including solid particulate sucrose, at 22 Filed: Jul. 31, 1980 least one triglyceride of a fatty acid having at least 8 30 Foreign Application Priority Data carbon atoms and a basic transesterification catalyst, at a temperature of from 110 to 140° C. at atmospheric Dec. 19, 1979 (GB) United Kingdom ..... ... 43762/79 pressure and in the absence of any solvent, is improved May 1, 1980 GB United Kingdom ............... 14370/80 by using a starting mixture which: 51) Int. Cl. ....................... C07H 13/06; C11D 1/66; (a) contains a di and/or mono-glyceride in an amount C11D 9/26; C11D 11/04 to provide a hydroxyl value of greater than 500 mg 52) U.S. -
The Effects of Polysorbate 80 on the Fat Emulsion in Ice Cream Mix: Evidence from Transmission Electron Microscopy Studies
Food Structure Volume 6 Number 2 Article 11 1987 The Effects of Polysorbate 80 on the Fat Emulsion in Ice Cream Mix: Evidence from Transmission Electron Microscopy Studies H. D. Goff M. Liboff W. K. Jordan J. E. Kinsella Follow this and additional works at: https://digitalcommons.usu.edu/foodmicrostructure Part of the Food Science Commons Recommended Citation Goff, H. D.; Liboff, M.; Jordan, W. K.; and Kinsella, J. E. (1987) "The Effects of Polysorbate 80 on the Fat Emulsion in Ice Cream Mix: Evidence from Transmission Electron Microscopy Studies," Food Structure: Vol. 6 : No. 2 , Article 11. Available at: https://digitalcommons.usu.edu/foodmicrostructure/vol6/iss2/11 This Article is brought to you for free and open access by the Western Dairy Center at DigitalCommons@USU. It has been accepted for inclusion in Food Structure by an authorized administrator of DigitalCommons@USU. For more information, please contact [email protected]. FOOD MICROSTRUCTURE, VoL 6 (1987), pp. 193- 198 0730-54 19/87$3 . 00+- . 00 Scanning Microscopy International , Chicago (AMF O'Hare). IL 60666 USA THE EFFECTS OF POLYSORBATE 80 ON THE FAT EMULSION IN ICE CREAM MIX EVIDENCE FROM TRANSMISSION ELECTRON MICROSCOPY STUDIES H. D. Goff", M. Uboff, W. K. Jordan, and J. E. Kinsella Institute of Food Science, Stocking Hall Cornell University, Ithaca, New York 14853 Introduction Emulsifiers are used in ice cream to produce a dry, smooth Emulsifiers, such as mono- and di -glycerides or textured product with desirable melting properties. They function polyoxyethylene sorbitan esters, are used in ice cream to improve by promoting a partial destabilization of the fat emulsion. -
Preparation of Sucrose Fatty Acid Esters As Food Emulsifiers and Evaluation of Their Surface Active and Emulsification Properties
280 Grasas y Aceites Vol. 50. Fase. 4 (1999), 280-282 Preparation of sucrose fatty acid esters as food emulsifiers and evaluation of their surface active and emulsification properties By Mohamed G. Megahed National Research Centre, Fats and Oils Department, Dokki, Cairo, Egypt. RESUMEN preparation of these compounds (Weiss et al., 1971, 1972; Bobaiek, 1977; Akoh and Swanson, 1987, Preparación de esteres de ácidos grasos con sacarosa 1989), however others excluded solvents in such como emulsionantes alimentarios y evaluación de sus propiedades superficiales y emulsionantes. preparation (Heesen et al., 1976; Rizzi and Taylor, 1978). Se ha llevado a cabo un método simple para la preparación de es It was planned to use a simple method for teres de sacarosa a partir de ácidos grasos y sacarosa de bajo coste. preparation of emulsifiers from sucrose and different Se han usado ácidos laurico, palmítico y oleíco en su preparación, en fatty acids (lauric, palmitic and oleic) aiming to ausencia de solventes orgánicos. Se obtuvieron rendimientos acepta bles del 86.5%, 87.3% y 88.6% para los ásteres del laurico, palmítico develop and improve the method of the preparation y oleíco respectivamente. of sucrose esters. Therefore, it was objective to En los productos se evaluaron sus balances hidrófilo-lipófilo modify the method of Heesen et al., (1976) for the (HLB), sus propiedades de tensión superficial e interfacial así preparation of sucrose emulsifiers (solvent-free como su estabilidad en emulsiones. Los resultados mostraron que estos esteres de sacarosa exhiben propiedades similares a reaction) by replacing the expensive polyalcohols for las de los compuestos preparados comercialmente.